Lauren Merendino, Chief Commercial Officer at Myovant Sciences Ltd. (MYOV), sold 14,098 shares at $10.45 ($147K) on 2022-04-19, disclosed to the SEC on 2022-04-21.
Open-market sale of $147k MYOV by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.45 | 7,049 | $74K | 50.0% |
| 2 | $10.45 | 7,049 | $74K | 50.0% |
| Total | $10.45 avg | 14,098 | $147K | 100% |
| Filing → |
| DAWN | SELL | 2025-08-19 | $25K | — | Filing → |
| DAWN | SELL | 2025-05-19 | $25K | — | Filing → |
| MYOV | SELL | 2023-01-20 | $108K | — | Filing → |